CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-04 | Ketchum Steven B Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +131,700 | 131,700 | ||
| 2022-02-04 | Ketchum Steven B Chief Scientific Officer | Grant or award · Restricted Stock Units | +103,700 | 103,700 | ||
| 2022-02-04 | Marks Jason M. Sr. VP and Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +131,700 | 131,700 | ||
| 2022-02-04 | Marks Jason M. Sr. VP and Chief Legal Officer | Grant or award · Restricted Stock Units | +103,700 | 103,700 | ||
| 2022-02-04 | Mikhail Karim President and CEO | Grant or award · Stock Option (Right to Buy) | +791,300 | 791,300 | ||
| 2022-02-04 | Mikhail Karim President and CEO | Grant or award · Restricted Stock Units | +623,100 | 623,100 | ||
| 2022-01-31 | Berg Aaron EVP, President US | Option exercise | +12,733 | 375,751 | ||
| 2022-01-31 | Berg Aaron EVP, President US | Option exercise · Restricted Stock Units | −12,733 | 0 | ||
| 2022-01-31 | Kalb Michael Wayne SVP and CFO | Option exercise | +12,733 | 245,944 | ||
| 2022-01-31 | Kalb Michael Wayne SVP and CFO | Shares withheld for taxes | −5,317 | $3.36 | $18K | 240,627 |
| 2022-01-31 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −12,733 | 0 | ||
| 2022-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +12,733 | 491,208 | ||
| 2022-01-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −5,121 | $3.36 | $17K | 486,087 |
| 2022-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −12,733 | 0 | ||
| 2022-01-10 | WOLD OLSEN PER Director | Grant or award · Stock Option (Right to Buy) | +103,569 | 103,569 | ||
| 2022-01-10 | WOLD OLSEN PER Director | Grant or award · Restricted Stock Units | +81,082 | 81,082 | ||
| 2021-12-31 | Berg Aaron EVP, President US | Option exercise | +47,767 | 363,018 | ||
| 2021-12-31 | Berg Aaron EVP, President US | Option exercise · Restricted Stock Units | −47,767 | 95,533 | ||
| 2021-12-31 | Kalb Michael Wayne SVP and CFO | Option exercise | +47,767 | 258,590 | ||
| 2021-12-31 | Kalb Michael Wayne SVP and CFO | Shares withheld for taxes | −25,379 | $3.35 | $85K | 233,211 |
Page 21 of 67 · 1,339 trades